Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study-Reference-Cited by-同舟云学术

Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A prospective cohort study

Published:2023-08 Issue: Volume:133 Page:36-42
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Huiberts Anne J.^ORCID,de Gier Brechje,Hoeve Christina E.,de Melker Hester E.,Hahné Susan J.M.,den Hartog Gerco^ORCID,Grobbee Diederick E.,van de Wijgert Janneke H.H.M.^ORCID,van den Hof Susan,Knol Mirjam J.^ORCID

Funder

Ministerie van Volksgezondheid, Welzijn en Sport

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference28 articles.

1. Vaccination programmes: epidemiology, monitoring, evaluation;Hahné,2021

2. The National Immunisation Programme in the Netherlands. Surveillance and developments in 2021–2022;Pluijmaekers,2022

3. Vaccinatiegraad COVID-19 vaccinatie Nederland, 2021;Valk,2022

4. Archief wekelijkse update vaccinatiecijfers 2022,2022

5. Effectiviteit van COVID-19-vaccinatie tegen SARS-CoV-2 infectie in de Delta periode,2021

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccination-induced antibody responses and waning by age and comorbidity status in a large population-based prospective cohort study;Vaccine;2024-11

2. Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022;International Journal of Infectious Diseases;2024-09

3. Unlocking the puzzle: non-defining mutations in SARS-CoV-2 proteome may affect vaccine effectiveness;Frontiers in Public Health;2024-08-15

4. SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response;Influenza and Other Respiratory Viruses;2024-06

5. BBIBP-CorV vaccine effectiveness against COVID-19 in patients aged 60 years and older during the Delta-dominant period in the Federation of Bosnia and Herzegovina, a test-negative case-control study;Vaccine;2024-05